HeatherAnneParsonsMDMPH

PubMed

• FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA.
  Yaping Liu, Sarah C Reed, Christopher Lo, Atish D Choudhury, Heather A Parsons, Daniel G Stover, Gavin Ha, Gregory Gydush, Justin Rhoades, Denisse Rotem, Samuel Freema...> ;Nature Communications. 2024 Mar 30
• Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
  Filipa Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christophe...> ;Nature Communications. 2024 Mar 27
• Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer.
  Morganti, S., Gibson, C., Jin, Q., Santos, K., Patel, A., Wilson, A., Merrill, M., Vincuilla, J., Stokes, S., Lipsyc-Sharf, M., Parker, T., King, T., Mittendorf, E., C...> ;Journal of Clinical Oncology. 2024 Jan 8
• FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA.
  Yaping Liu, Sarah C Reed, Christopher Lo, Atish D Choudhury, Heather A Parsons, Daniel G Stover, Gavin Ha, Gregory Gydush, Justin Rhoades, Denisse Rotem, Samuel Freema...> ;Biorxiv. 2024 Jan 2
• Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping.
  Sylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu, Talal El Zar...> ;Nature Medicine. 2024 Mar 1
• Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
  Filipa Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christophe...> ;Medrxiv. 2023 Dec 4
• 4 citations
  Liquid biopsy epigenomic profiling for cancer subtyping.
  Sylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu, Talal El Zar...> ;Nature Medicine. 2023 Nov 1
• Circulating Tumor DNA in Breast Cancer: Current and Future Applications.
  Arielle J Medford, Elyssa N Denault, Beverly Moy, Heather A Parsons, Aditya Bardia> ;Clinical Breast Cancer. 2023 Oct 1
• 1 citations
  Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer.
  Stefania Morganti, Heather A Parsons, Nancy U Lin, Albert Grinshpun> ;NPJ Breast Cancer. 2023 May 24
• 7 citations
  Single duplex DNA sequencing with CODEC detects mutations with high sensitivity.
  Jin H Bae, Ruolin Liu, Eugenia Roberts, Erica Nguyen, Shervin Tabrizi, Justin Rhoades, Timothy Blewett, Kan Xiong, Gregory Gydush, Douglas Shea, Zhenyi An, Sahil Patel...> ;Nature Genetics. 2023 May 1
• 3 citations
  Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.
  Heather A Parsons, Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong, Vandana G Abramson, Ashka Patel, Ju Cheng, Adam Brufsky, Justin Rhoade...> ;Medrxiv. 2023 Mar 8
• Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA.
  Anna-Lisa Doebley, Minjeong Ko, Hanna Liao, A Eden Cruikshank, Katheryn Santos, Caroline Kikawa, Joseph B Hiatt, Robert D Patton, Navonil De Sarkar, Katharine A Collie...> ;Nature Communications. 2023 Jan 25
• 19 citations
  A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA.
  Anna-Lisa Doebley, Minjeong Ko, Hanna Liao, A Eden Cruikshank, Katheryn Santos, Caroline Kikawa, Joseph B Hiatt, Robert D Patton, Navonil De Sarkar, Katharine A Collie...> ;Nature Communications. 2022 Dec 3
• 1 citations
  'ADVANCE' (a pilot trial) ADjuVANt chemotherapy in the elderly: Developing and evaluating lower-toxicity chemotherapy options for older patients with breast cancer.
  Rachel A Freedman, Tianyu Li, Mina S Sedrak, Judith O Hopkins, Nabihah Tayob, Meredith G Faggen, Natalie F Sinclair, Wendy Y Chen, Heather A Parsons, Erica L Mayer, Pa...> ;Journal of Geriatric Oncology. 2023 Jan 1
• 3 citations
  Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retr...
  Tal Sella, Pedro Exman, Siyang Ren, Taylor S Freret, Katherine E Economy, Wendy Y Chen, Heather A Parsons, Nancy U Lin, Beverly Moy, Nadine M Tung, Ann H Partridge, Na...> ;Breast Cancer Research and Treatment. 2022 Aug 1
• 8 citations
  Aiming for the Cure in ERBB2-Positive Metastatic Breast Cancer-Should We Go "All In"?-Reply.
  Heather A Parsons, Sara M Tolaney, Tarantino, P.> ;JAMA Oncology. 2022 Aug 1
• 29 citations
  Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
  Marla Lipsyc-Sharf, Elza C de Bruin, Katheryn Santos, Robert McEwen, Daniel Stetson, Ashka Patel, Gregory J Kirkner, Melissa E Hughes, Sara M Tolaney, Ann H Partridge,...> ;Journal of Clinical Oncology. 2022 Aug 1
• 4 citations
  Late Recurrence Following Early Breast Cancer.
  Alexandra Thomas, Heather A Parsons, Karen Lisa Smith> ;Journal of Clinical Oncology. 2022 May 1
• 14 citations
  Aiming at a Tailored Cure for ERBB2-Positive Metastatic Breast Cancer: A Review.
  Paolo Tarantino, Giuseppe Curigliano, Heather A Parsons, Nancy U Lin, Ian Krop, Elizabeth A Mittendorf, Adrienne Waks, Eric P Winer, Sara M Tolaney> ;JAMA Oncology. 2022 Apr 1
• 26 citations
  Massively parallel enrichment of low-frequency alleles enables duplex sequencing at low depth.
  Gregory Gydush, Erica Nguyen, Jin H Bae, Timothy Blewett, Justin Rhoades, Sarah C Reed, Douglas Shea, Kan Xiong, Ruolin Liu, Fangyan Yu, Ka Wai Leong, Atish D Choudhur...> ;Nature Biomedical Engineering. 2022 Mar 1
• 4 citations
  Association of 17q22 Amplicon Via Cell-Free DNA With Platinum Chemotherapy Response in Metastatic Triple-Negative Breast Cancer.
  Katharine Collier, Sarah Asad, David Tallman, Janet Jenison, Andrei Rajkovic, Elaine R. Mardis, Heather A. Parsons, Sara M. Tolaney, Eric P. Winer, Nan Lin, Gavin Ha, ...> ;JCO Precision Oncology. 2021 Nov 24
• 8 citations
  Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer
  Zachary Weber, Katharine Collier, David Tallman, Juliet Forman, Sachet A. Shukla, Sarah Asad, Justin Rhoades, Samuel S. Freeman, Heather A. Parsons, Nicole Williams, R...> ;Genome Medicine. 2021 May 20
• 3 citations
  Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor Cells
  Heather A. Parsons, Erin R. Macrae, Hao Guo, Tianyu Li, William T. Barry, Nabihah Tayob, Gerburg M. Wulf, Steven J. Isakoff, Ian E. Krop> ;JCO Precision Oncology. 2021 May 20
• 13 citations
  Adjuvant Capecitabine in Triple-Negative Breast Cancer: New Strategies for Tailoring Treatment Recommendations
  Heather A. Parsons, Harold J. Burstein> ;JAMA. 2021 Jan 5
• 6 citations
  Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches.
  David W Cescon, Kevin Kalinsky, Heather A Parsons, Karen Lisa Smith, Patricia A Spears, Alexandra Thomas, Fengmin Zhao, Angela DeMichele> ;Frontiers in Oncology. 2021 Jan 1
• Join now to see all

Journal Articles

• Tumor Fraction in Cell-Free DNA as a Biomarker in Prostate Cancer  
  Heather A. Parsons, Atish D. Choudhury, Lauren C. Harshman, Daniel G. Stover, The Journal of Clinical Investigation